New eye test detects earliest signs of glaucoma

A simple eye test could help to solve the biggest global cause of irreversible blindness, glaucoma.

The Wellcome-funded diagnostic – developed by researchers at University College London (UCL) and the Western Eye Hospital – allows doctors to see individual nerve cell death in the back of the eye.

Early detection means doctors can start treatment before sight loss begins. The test also has potential for early diagnosis of other degenerative neurological conditions, including Parkinson's, Alzheimer's and multiple sclerosis.

The results of the first with glaucoma patients are published today in the journal Brain.

Professor Francesca Cordeiro, at UCL Institute of Opthamology, who led the research, said: "Although detection has been improving, most patients have lost a third of vision by the time they are diagnosed.

"Now, for the first time, we have been able to show individual cell death and detect the earliest signs of glaucoma. While we cannot cure the disease, our test means treatment can start before symptoms begin."

Glaucoma affects 60 million people worldwide and one in ten go blind.

The new technique means patients could be diagnosed up to ten years earlier than is currently possible.

Bethan Hughes, Wellcome's Strategic Development Lead for Innovation, said: "This innovation has the potential to transform lives for those who suffer loss of sight through glaucoma, and offers hope of a breakthrough in of other neurodegenerative diseases."

How the DARC eye test works

Loss of sight in patients with glaucoma is caused by the death of cells in the retina at the back of the eye – apoptosis.

The is called DARC, which stands for detection of apoptosing retinal cells.

It uses a specially developed fluorescent marker which attaches to cell proteins when it's injected into patients. Damaged appear as white fluorescent spots during eye examination.

Initial clinical trials were carried out on a small number of glaucoma and compared with tests on healthy people to establish the 's safety.

DARC uses equipment that is already part of routine hospital eye examinations.

The researchers hope that eventually it may be possible for opticians to do the tests. This would mean even earlier detection of the disease.

Treatment for is much more successful when it is begun in the early stages of the disease.

Further studies will now be carried out into DARC and how it could be used to detect other neurodegenerative conditions where increasing numbers of nerve are lost as the disease progresses.

Explore further

New eye test could detect glaucoma years earlier

More information: Maria F. Cordeiro et al. Real-time imaging of single neuronal cell apoptosis in patients with glaucoma, Brain (2017). DOI: 10.1093/brain/awx088
Journal information: Brain

Provided by Wellcome Trust
Citation: New eye test detects earliest signs of glaucoma (2017, April 27) retrieved 8 July 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments